Enzyme vs Tria — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Tria trades at Rp149.24 (market cap Rp322,2M, Rp169,04M 24h volume). The key difference: Tria is far larger — about 2.4× Enzyme's market cap, and Tria's supply is capped (2,2B / 10B TRIA (22%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 28 Days and Tria for 3 Days on average.
| MLN | TRIA | |
|---|---|---|
Market Cap | Rp134,13M | Rp322,2M |
Volume (24h) | Rp104,56M | Rp169,04M |
Circulating Supply | 3,3M MLN | 2,2B / 10B TRIA (22%) |
Typical Hold Time | 28 Days | 3 Days |
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) currently holds a market capitalization of Rp134.13 million with a circulating supply of 3.3 million tokens. The asset shows moderate market activity with a hold time of 28 days indicating average investor retention. Recent market data suggests stable trading patterns within the decentralized finance ecosystem, though specific price action requires current exchange verification.
Outlook remains cautiously neutral given limited recent protocol updates. Key opportunities include potential DeFi ecosystem growth integration, while risks center on typical crypto volatility and regulatory uncertainty. Investors should monitor on-chain activity and exchange liquidity for clearer directional signals.
TRIA is currently trading at Rp147.744 with a market cap of Rp318.05M, showing bearish technical signals with moving averages indicating selling pressure while oscillators remain neutral. The token trades near support level S1 at Rp146, with only 22% of the maximum 10M supply in circulation. Recent trading activity shows a short average hold time of 3 days, suggesting speculative interest.
Overall outlook remains cautious with bearish technical indicators dominating. Key opportunities include potential rebound from oversold RSI levels, while major risks include low liquidity, high volatility, and limited fundamental developments. Investors should monitor support levels closely for potential entry points.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →Tria is a self-custodial crypto neobank and cross-chain routing engine that enables seamless spending, trading, and earning within one application. It addresses blockchain fragmentation through its BestPath routing technology, enabling gasless, bridge-free transactions and card payments directly from user-controlled wallets. The TRIA token supports rewards, ecosystem access, and governance participation.
Read more on TRIA →